Benign Prostatic Hyperplasia Treatment Market To Be Worth ~$17 Billion by 2030 Says P&S Intelligence |
| June 24, 2021 | June 2021 Bond Updates |
|
NEW YORK, June 24, 2021 /PRNewswire/ -- The global benign prostatic hyperplasia treatment market is expected to reach a value of around $17 billion by 2030. The surging geriatric population, rising incidence of prostate cancer, growing awareness about prostate cancer and its treatment... |
| View more at: https://www.prnewswire.com:443/news-releases/benign-prostatic-hyperplasia-treatment-market-to-be-worth-17-billion-by-2030-says-ps-intelligence-301319088.html |
| Related News |